ors • Combination of novel scaffold and pro-drug technology • Orally bioavailable pro.drug designed to be liver targeting 29 29 EFTA00506098 EPB-510 has an highly competitive in vitro & in vivo profile for an HCV NPI 100 Discovery & Development • Epiphany discovered ENS-510 as part of its Int